⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7709747 | 0.77 | — | — | |
| SCHEMBL9550891 | 0.74 | — | — | |
| SCHEMBL9247504 | 0.74 | — | — | |
| SCHEMBL9344803 | 0.74 | — | — | |
| SCHEMBL3246341 | 0.72 | — | — | |
| SCHEMBL9471974 | 0.72 | — | — | |
| SCHEMBL320247 | 0.67 | — | — | |
| SCHEMBL8370302 | 0.67 | — | — | |
| SCHEMBL11129424 | 0.67 | — | — | |
| SCHEMBL1714328 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040110729-A1 | Primary N-hydroxylamines | NIH | 2004-06-10 | — | — | US | claimed |
| US-20040102420-A1 | Primary N-hydroxylamines | NIH | 2004-05-27 | — | — | US | claimed |
| US-20030153535-A1 | Primary N-hydroxylamines | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2003-08-14 | — | — | US | claimed |
| US-6455589-B1 | AN ORALLY ADMINISTRABLE EFFECTIVE UNIT SOLID DOSAGE OF A PRIMARY N-HYDROXYLAMINE OR A SALT, FREE OF NITRONE; USEFUL FOR REDUCING OXIDATIVE DAMAGE OR DELAYING SENESCENCE | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2002-09-24 | — | — | US | claimed |
| WO-2001030979-A1 | PRIMARY N-HYDROXYLAMINES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2001-05-03 | — | — | WO | claimed |
| US-20080268537-A1 | PRIMARY N-HYDROXYLAMINES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2008-10-30 | — | — | US | disclosed |
| US-20040110729-A1 | Primary N-hydroxylamines | NIH | 2004-06-10 | — | — | US | disclosed |
| US-20040102420-A1 | Primary N-hydroxylamines | NIH | 2004-05-27 | — | — | US | disclosed |
| US-20030153535-A1 | Primary N-hydroxylamines | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2003-08-14 | — | — | US | disclosed |
| US-6455589-B1 | AN ORALLY ADMINISTRABLE EFFECTIVE UNIT SOLID DOSAGE OF A PRIMARY N-HYDROXYLAMINE OR A SALT, FREE OF NITRONE; USEFUL FOR REDUCING OXIDATIVE DAMAGE OR DELAYING SENESCENCE | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2002-09-24 | — | — | US | disclosed |
| WO-2001030979-A1 | PRIMARY N-HYDROXYLAMINES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2001-05-03 | — | — | WO | disclosed |
| CN-1137280-A | Water soluble active sulfones of poly (ethylene glycol) and relative polymer for modifying surface and molecule of substances | SHEARWATER POLYMERS INC (US) | 1996-12-04 | — | — | CN | disclosed |
| US-4191613-A | BONDED TO HAPTEN | SYVA COMPANY (US) | 1980-03-04 | — | — | US | disclosed |